An article published in Cell Chemical Biology by scientists at the Institute for Research in Biomedicine (IRB Barcelona) describes a new class of prolyl oligopeptidase (POP) inhibitors.
Research Programmes / Core Facilities
Cell and Developmental Biology
Structural and Computational Biology
Chemistry and Molecular Pharmacology
Core Facilities & Services
Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.
IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine
Selected IRB Barcelona publications
Noticias & Eventos
Researchers develop a new class of covalent inhibitor for a protein involved in brain diseases
Key protein in sperm tail assembly identified
An ERC Proof of Concept grant to fight drug resistance in breast cancer
DOR protein deficiency favours the development of obesity
23MayLysosomal degradation pathways in Drosophila: autophagy, endo/phagocytosis and crinophagy
25MayN-Myc co-ordinating global transcription with DNA replication
30MayNon-coding RNAs in cardiometabolic disease
30MayCoupling Neurogenesis to Circuit Formation
The group led by ICREA Research Professor Cayetano Gonzalez at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with Giuliano Callaini’s team at the University of Siena i
The European Research Council (ERC) has announced the first round of 2018 ERC Proof of
Obesity is a world health problem since excessive accumulation of fat tissue (or adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer.